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Abstract
Background: The hypothesis of dosage compensation of genes of the X chromosome, supported by previous microarray studies,
was recently challenged by RNA-sequencing data. Itwassuggested thatmicroarray studies were biased toward an over-estimation
of X-linked expression levels as a consequence of the filtering of genes below the detection threshold of microarrays.
Methodology/Principal Findings: To investigate this hypothesis, we used microarray expression data from circulating
monocytes in 1,467 individuals. In total, 25,349 and 1,156 probes were unambiguously assigned to autosomes and the X
chromosome, respectively. Globally, there was a clear shift of X-linked expressions toward lower levels than autosomes. We
compared the ratio of expression levels of X-linked to autosomal transcripts (X:AA) using two different filtering methods: 1.
gene expressions were filtered out using a detection threshold irrespective of gene chromosomal location (the standard
method in microarrays); 2. equal proportions of genes were filtered out separately on the X and on autosomes. For a wide
range of filtering proportions, the X:AA ratio estimated with the first method was not significantly different from 1, the value
expected if dosage compensation was achieved, whereas it was significantly lower than 1 with the second method, leading
to the rejection of the hypothesis of dosage compensation. We further showed in simulated data that the choice of the
most appropriate method was dependent on biological assumptions regarding the proportion of actively expressed genes
on the X chromosome comparative to the autosomes and the extent of dosage compensation.
Conclusion/Significance: This study shows that the method used for filtering out lowly expressed genes in microarrays may
have a major impact according to the hypothesis investigated. The hypothesis of dosage compensation of X-linked genes
cannot be firmly accepted or rejected using microarray-based data.
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Introduction
It is widely admitted that in mammals, X-linked genes are
upregulated to ensure balanced expression between the X
chromosome, present in a single active copy per cell, and
autosomes, present in two copies [1]. The hypothesis of dosage
compensation first proposed by Ohno in 1967 [2] was supported
by recent microarray studies showing that X-linked genes were
expressed at similar levels to autosomal genes in mice and humans
[3–5]. However, the molecular mechanism responsible for this
compensation is still not understood [6]. The absence of
mechanistic interpretation, coupled to the lack of dosage
compensation in other taxa [7,8], have spurred speculation about
this phenomenon.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e23956Recently, Ohno’s hypothesis was challenged by a study using
RNA sequencing (RNA-Seq) data showing that the ratio of the
median expression level of X-linked genes to that of autosomal
genes (X:AA) was significantly lower than 1 in different human
and mouse tissues [9]. The authors attributed the difference
between their findings and previous ones to the fact that RNA-Seq
is much more sensitive than microarray to detect small expression
differences [9–11] and that microarray studies are likely to be
biased towards an over-estimation of X-linked expression levels as
a consequence of the filtering of genes considered to be under the
detection threshold of microarray [9]. This controversial finding
led us to question the method conventionally used for the analysis
of microarray-based expression data. Using data from a large-scale
expression study in human monocytes [12], we showed that
according to the method used for filtering out the genes prior to
analysis, the inference regarding dosage compensation was in the
opposite direction. A simulation study further demonstrated that
the choice of the most appropriate filtering method was dependent
on biological assumptions regarding the proportion of actively
expressed genes on the X chromosome and on autosomes and the
extent of dosage compensation. Although the limited sensitivity of
microarrays does not allow one to go further in resolving this issue,
the potential methodological bias arising from using a signal-
threshold cutoff in microarray experiments should be kept in mind
when comparing expression across loci.
Results
Filtering transcripts considered as undetected by
microarrays may discard genes that show biologically
relevant associations supporting cellular expression
In microarray studies, genes whose expression is not signifi-
cantly different from the background signal are conventionally
filtered out prior to analysis. These genes are often inappropriately
considered as unexpressed in the cell type under study although
they are only undetected. Recent studies based on RNA-Seq have
shown that a fraction of the genes undetected by microarrays were
actually expressed at low levels in the cells investigated [9,10,13].
This filtering based on a statistical detection criterion was justified
in former small microarray studies which were mainly designed for
discovering large expression differences between contrasted
experimental conditions and therefore focused on highly expressed
genes. However, it may be less appropriate in current large-scale
transcriptomic studies which are more interested in characterizing
the natural sources of variability of gene expression, such as
genetic variations, environmental exposures, metabolic conditions,
ageing or gender [12]. Actually, a gene expression level that is
below the detection threshold of microarrays may be found to be
related to a SNP or another relevant factor that provides biological
evidence that the gene is expressed. This is a problem known as
signal-to-noise in biology [14].
To illustrate this issue, we re-analyzed the data of a previous
study in which gene expression was simultaneously measured by
microarray and RNA-Seq in two different cell lines, HEK and B
cells [10]. In this study, RNA-Seq could detect 25% more gene
expressions than could microarrays. When the authors focused on
genes detected by both platforms and in both cell lines (n=7,043),
they showed that the differences of gene expression between HEK
and B cells (measured by the log ratio of expression) strongly
correlated across the two platforms (r=0.88) in spite of a
compression effect resulting in smaller ratios in microarrays. This
result indicated that true biological differences between cell types
were reproducibly found across platforms. Using the same dataset,
we performed a similar analysis on the genes that were detected by
RNA-Seq (at least five reads) but were undetected by microarray
(detection score ,0.95) (1,640 genes). As shown in Figure 1, there
was a subset of genes lying along the diagonal in which differential
expression between HEK and B cells strongly correlated across the
two platforms. For these genes, which are likely to be truly
differentially expressed between cell types, the difference could be
detected by microarrays even though their expression level was
considered not different from the background noise. This
demonstrates that for genes below the detection level of
microarrays, biologically relevant signals can be found that
indicate that the gene is expressed.
Testing the hypothesis of dosage compensation of X-
linked genes in human monocytes
To investigate the hypothesis of dosage compensation of X-
linked genes, we used expression data from the Gutenberg Heart
Study (GHS), a population-based study in which the transcriptome
of circulating monocytes was assessed in 1,467 unrelated subjects
(51.1% of men) by microarray using the Illumina HT-12 v3
BeadChip [12]. After removing probes with a bad quality score
according to ReMOAT [15], 25,349 probes were unambiguously
assigned to the autosomes and 1,156 probes to the X chromosome.
Analyses were performed at the probe level and for simplicity the
term of ‘‘transcript’’ was used to denote a unique probe-
hybridization product (although in few cases the same transcript
could be targeted by several probes or conversely, a same probe
could target several transcripts). Analyses were performed in males
and females separately.
As usually performed in microarray experiments, we first
selected the transcripts whose expression was detected in $95% of
samples. This filtering resulted in the selection of 10,896
autosomal and 360 X-linked transcripts, the vast majority of them
being detected in both genders. The proportion of transcripts
filtered out prior to analysis was 57.5% as a whole, but it was
much higher on the X chromosome than on autosomes (68.9% vs
57.0%, P,10
26). In the subset of selected transcripts, the median
level of expression of X-linked transcripts was not significantly
different from that of autosomal transcripts in both sexes (7.68 vs
7.87, P=0.09 in males; 7.71 vs 7.85, P=0.12 in females). As
previously reported [5], expression levels of X-linked genes fell
within the global range of autosomes, suggesting that dosage
compensation of X-linked genes was globally achieved in both
sexes (Figures 2A and 2B).
However, as shown by the quantile functions of expression levels
plotted separately for the X chromosome and for autosomes, there
was a clear shift of X-linked expressions towards lower levels than
autosomes in both sexes (Figures 3A and 3B). As a consequence,
taking a uniform detection threshold for the X and for autosomal
chromosomes led to a greater truncation of transcripts on the X
chromosome than on autosomes (as shown by the horizontal plain
red line in Figures 3A and 3B) resulting in an over-estimation of X-
linked expressions in the subset of genes kept for analysis. In order
to circumvent this potential bias, we compared expression levels
between X-linked and autosomal transcripts after excluding equal
proportions of the less expressed transcripts on the X and on
autosomes separately (as shown by the vertical green line in
Figures 3A and 3B). When excluding the same proportion of
transcripts as above (57.5%), but considering this time the X
chromosome and autosomes separately, the difference of median
expression levels between X-linked and autosomal transcripts
became highly significant in both sexes (6.82 vs 7.91, P,10
231 in
males; 6.85 vs 7.91, P,10
230 in females).
We then compared the X:AA ratio of expression level of X-
linked transcripts to autosomal transcripts when filtering either a
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their chromosome location (model 1 which is equivalent to
considering a uniform detection threshold) or an equal proportion
of the lowest gene expressions on the X and on autosomes
separately (model 2). In order to investigate the impact of the
filtering threshold on the estimation of the X:AA ratio, we varied
the proportion of filtered transcripts, which corresponded to
moving the horizontal red lines from the bottom to the top (model
1) or the vertical green lines from the left to the right (model 2) in
Figures 3A and 3B. As shown in Figures 4A and 4B, the X:AA
ratio was always higher when using a uniform filtering threshold
not depending on the gene chromosomal location (model 1, red
triangles) than when using a chromosome-specific threshold
(model 2, green circles). The difference between the two X:AA
estimates increased as the filtering became more stringent as a
result of a greater truncation in model 1 of lowly expressed genes
on the X chromosome than on autosomes. When the proportion
of genes filtered out prior to analysis was greater or equal to 50%,
the X:AA ratio estimated when taking a uniform filtering threshold
was no longer significantly different from 1, the value expected if
there was dosage compensation, whereas it was significantly lower
than 1 when taking a chromosome-specific threshold. Results were
very similar in males and females (Figure 4A and 4B).
We also estimated the X:AA ratio for each autosome
individually after filtering out the same proportion (50%) of the
lowest gene expressions on each chromosome. For all autosomes,
the X:AA ratio was significantly lower than 1 (Figure 4C and 4D).
Worthy of note, the X:AA ratio associated to chromosome 21,
which was the highest in human liver RNA-seq data [9], was also
the highest in human monocytes.
The number of probes per gene was slightly higher on the X
chromosome than on autosomes (1.64 vs 1.51). To check whether
this difference might have an impact on the results, we repeated
the analysis using the most variable probe for each gene or using
average expression across probes. Although the X:AA ratio tended
to be slightly higher than when focusing on probes, the same
trends were observed (Figure S1).
Dosage compensation of X-linked genes in other human
and mouse tissues
Because the expression of genes is known to be tissue specific,
we checked whether the same observation could be made from
other tissues. For this purpose, we analyzed publicly available
microarray expression data from three different human tissues, the
meibomian glands (access number GSE17822), the muscle (access
number GSE20319) and the colon (access number GSE26305).
For each tissue dataset, we selected either the transcripts for which
the detection score was greater than 95% (filtering not depending
of chromosome), or the same proportion (arbitrarily taken to 50%)
of the most highly expressed transcripts separately on the X
chromosome and on autosomes. Whatever the tissue under
consideration, the differences of expression levels between X-
linked and autosomal genes were always more pronounced when
filtering out separately genes on the X and on autosomes (Figure 5).
Figure 1. Comparison of differentially expressed genes (B versus HEK cells) by RNA sequencing and microarrays. Data are drawn from
Sultan et al. [10] and genes detected by RNA-Seq (at least five reads) but not detected by microarrays (detection score ,0.95) were selected (1,640
genes in total). The plot shows log2 ratios of expression in RNA-Seq (x axis) and microarrays (y axis).
doi:10.1371/journal.pone.0023956.g001
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from mouse heart tissue (access number GSE27689) (Figure 5).
Unlike what had been previously reported from RNA-Seq data
[9], we did not observe a lower X:AA ratio in mice than in
humans in this mouse dataset (Figure S2).
Comparison with genes submitted to genomic
imprinting
In mammals, genomic imprinting affects a small proportion
(,1%) of autosomal genes and results in the expression of only one
allele inherited from the father or the mother. In terms of
expressed alleles, imprinted genes are thus comparable to X-linked
genes which are submitted to inactivation of one of the two alleles.
We hypothesized that imprinted genes may exhibit a similar
pattern of expression to the one observed in X-linked genes.
To test this hypothesis, we compared the levels of imprinted
transcripts to those of non-imprinted transcripts in the GHS
dataset. Among the 10,806 well-annotated autosomal probes, 97
probes (listed in Table S1) corresponded to genes that were
reported to be submitted to imprinting in two databases (http://
igc.otago.ac.nz/home.html and http://www.geneimprint.com/).
When first selecting the transcripts whose expression was detected
in $95% of samples, the proportion of transcripts filtered out prior
to analysis was much higher for imprinted than for non-imprinted
transcripts (72.2% vs 57.3%, P,10
26). In the subset of selected
transcripts, the median level of expression of imprinted transcripts
was not significantly different from that of non-imprinted
transcripts (8.32 vs 8.08, P=0.88). By contrast, when selecting a
similar proportion (arbitrarily taken to 50%) of the most highly
expressed transcripts separately among imprinted and non-
Figure 2. Box plots of the median expression levels in human monocytes according to chromosome when selecting the transcripts
detected in at least 95% of individuals. (A) Males and (B) Females.
doi:10.1371/journal.pone.0023956.g002
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imprinted transcripts than in non-imprinted ones (6.89 vs 7.78,
P,0.001) (Figure 6).
Simulation study
By filtering out the same proportion of genes on each
chromosome, we implicitly make the assumption that the same
proportion of genes are actively expressed on the X chromosome
andonautosomes,anassumptionthatmaynotbetrue,atleastinall
tissues. We addressed this issue using the gene expression dataset
from HEK and B cells already used above [7]. In HEK cells, the
proportions of genes actively expressed (i.e. detected by RNA-Seq)
on autosomes and on the X chromosome were relatively similar
(81.2% vs 76.8%, P=0.02), whereas in B cells, these proportions
were globally lower and differed more drastically between
autosomes and the X (70.0% vs 58.8%, P=2.4610
26). These
results suggested that the assumption of equal proportionality of
expressed genes by chromosome may not hold in all cell types.
We further explored the impact of different assumptions using
simulations. We simulated expression data assuming either an
equal proportion of actively expressed genes on autosomes and on
the X (80% as in HEK cells), or a lower proportion on the X than
on autosomes (60% vs 70% as in B cells). For each cell type, we
additionally assumed that there was either full dosage compensa-
tion (X:AA ratio=1), partial compensation (X:AA ratio=0.75) or
complete lack of compensation (X:AA ratio=0.5). Expression
levels were simulated according to the model proposed by Lin et
al. [16] with parameters based on the empirical values observed in
the GHS dataset (see Methods). The X:AA ratio was then
estimated using the two different methods for filtering out gene
expressions (referred to as ‘‘uniform filtering’’ and ‘‘chromosome-
specific filtering’’, respectively). For both methods, the proportion
of filtered genes was fixed at 50% and the null hypothesis tested
was that of full dosage compensation. Results of the simulation
study are presented in Figure 7.
Under the assumption of equal proportions of expressed genes
(as in HEK cells), both methods correctly estimated the X:AA ratio
to 1 when there was full compensation. When there was partial
compensation, the uniform filtering method did not allow the
rejection of the null hypothesis whereas the chromosome-specific
Figure 3. Quantile functions of median expression levels of X-linked and autosomal transcripts in human monocytes. (A) Males and
(B) Females: X-linked transcripts are shown by the plain black curve, autosomal transcripts by the dashed black curve and each autosome by an
individual grey curve. For a probability p (x-axis), the y-axis shows the median expression level below which p6100% of transcripts fall. The horizontal
red line corresponds to the filtering performed when selecting transcripts detected in $95% of individuals. The vertical green line corresponds to
excluding equal proportions (57.5%) of the less expressed genes on the X chromosome and on autosomes separately.
doi:10.1371/journal.pone.0023956.g003
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both methods allowed the rejection of the null hypothesis.
Under the assumption of different proportions of expressed
genes (as in B cells), the chromosome-specific filtering method
tended to globally under-estimate the true X:AA ratio, leading to
falsely reject the null hypothesis of compensation when this latter
was true, whereas in that case the uniform filtering method
correctly estimated the X:AA ratio. For partial compensation,
again the uniform filtering method did not allow the rejection of
the null hypothesis whereas the chromosome-specific filtering
method did. Both methods allowed the rejection of the null
hypothesis when there was no compensation.
Discussion
The present study addresses an important issue concerning
the potential biases arising from the method of filtering genes in
expression studies. In microarray studies, it is generally
advocated to select only the genes whose expression is detected
in the majority of samples, the remaining genes being
Figure 4. Comparison of expression levels between the X chromosome and autosomes in human monocytes. (A) Males and (B)
Females: The graph plots the X:AA ratio of median expression of X-linked genes to autosomal genes according to the proportion of transcripts
filtered out prior to analysis, using either a uniform threshold (red triangles) or individual thresholds on the X and on autosomes (green circles). Error
bars show the 95% bootstrap confidence intervals. The horizontal dashed lines show the ratios expected if there was no dosage compensation
(X:AA=0.5) or full compensation (X:AA=1). The vertical line corresponds to the proportion of genes filtered out when using a detection score $95%.
(C) Males and (D) Females: X:AA ratios when the X is compared to individual autosomes and the same proportion of transcripts (50%) is filtered on
the X and on each autosome.
doi:10.1371/journal.pone.0023956.g004
Figure 5. Expression levels of X-linked and autosomal transcripts in different human and mouse tissues. The graph shows boxplots of
expression levels either when filtering the genes according to a uniform detection threshold (detection score (DS) $95%) or when excluding the 50%
lowest gene expressions separately on the X chromosome and on autosomes (AUT).
doi:10.1371/journal.pone.0023956.g005
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However, with the advent of more sensitive techniques like
RNA-Seq, as well as the greater power of contemporary
transcriptomic studies, it is realized that many genes considered
as unexpressed in microarray experiments are actually ex-
pressed at low levels, or only in a fraction of the population, for
example when expression is modulated by a genetic or an
environmental factor.
Figure 6. Expression levels of imprinted and non-imprinted autosomal transcripts in human moncoytes. The graph shows boxplots of
expression levels either when filtering the genes according to a uniform detection threshold (detection score (DS) $95%) or when excluding the 50%
lowest gene expressions separately in imprinted and non-imprinted genes.
doi:10.1371/journal.pone.0023956.g006
Figure 7. X:AA ratio estimated from data simulated under different models of dosage compensation and assuming variable
proportions of expressed genes on the X and on autosomal chromosomes (see legend of x axis). In all cases, 50% of transcripts were
filtered out prior to analysis, using either a uniform threshold (red triangles) or individual thresholds on the X and on autosomes (green circles).
doi:10.1371/journal.pone.0023956.g007
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across loci, as for the analysis of dosage compensation comparing
genes on different chromosomes. We showed that analyzing data
by conventional filtering methods of microarrays led to the
conclusion that in human monocytes, expression levels of X-linked
genes did not differ from those of autosomal genes. This result
would support the hypothesis of dosage compensation of X-linked
genes, as reported by previous microarray studies [3–5]. On the
other hand, if there is no dosage compensation, as recently
suggested by RNA-Seq data [9], expression levels of X-linked
genes are expected to be lower than those of autosomal genes.
Applying the standard filtering threshold of microarrays would
then bias the results by excluding a disproportionate number of
lowly expressed genes on the X chromosome. When applying a
chromosome-specific filtering threshold to circumvent this bias,
the hypothesis of dosage compensation was no longer supported
by the data. However, the use of a chromosome-specific threshold
implicitly rests on the assumption that the same proportion of
genes are expressed on the X chromosome and on autosomes, an
assumption which may hold in some cell types but not in others, as
suggested by the comparison of HEK and B cells. Depending on
the underlying biological reality, we showed by simulations that
either method of filtering might lead to false inference. This
potential bias should be kept in mind in analysis of microarray
experiments. Hopefully, this should be no longer an issue with the
development of highly sensitive technologies for the quantification
of transcript abundance such as RNA-Seq. Interestingly, in a
recent RNA-Seq study on mouse Th2 cells, two distinct groups of
genes could be detected, one group of lowly expressed and
putatively non-functional mRNAs, and the other group of highly
expressed and functional mRNAs [13]. This suggests that the
distinction between expressed and non-expressed genes may be
even more subtle than initially thought.
Materials and Methods
Ethic statement
The study protocol and drawing of the blood sample have been
approved by the local ethics committee and by the local and
federal data safety commissioners (Ethik-Kommission der Land-
esa ¨rztekammer Rheinland-Pfalz 22/03/2007 Number 837.020.07
(5555)). All subjects included signed an informed consent.
Study Population
The study has been described in details elsewhere [12]. Study
participants of both sexes aged 35–74 yr, were successively
enrolled into the Gutenberg Heart Study (GHS), a community-
based single centre cohort study conducted in the Rhein-Main
region in western mid-Germany. All subjects were of European
descent. Individuals for whom we found a discrepancy between
the phenotypic gender and the sex inferred from expression of Y-
linked transcripts were excluded, leaving 1,467 individuals for
analysis (750 men and 717 women).
Genome-wide expression
Genome-wide expression profiles were assessed from peripheral
blood monocytes. Separation of monocytes was conducted within
60 min after blood collection by negative selection using
RosetteSep Monocyte Enrichment Cocktail (StemCell Technolo-
gies, Vancouver, Canada). Total RNA was extracted the same day
using Trizol extraction and purification by silica-based columns.
Expression profiles were assessed using the Illumina HT-12 v3
BeadChip. The pre-processing of data was performed using
Beadstudio. Values from probes with #1 bead were re-imputed
using the SVD impute from the pcaMethods R package. Data
were normalized using quantile normalization and VST transfor-
mation [16] as implemented in the lumi R package [17]. After
removing probes with a bad quality score according to ReMOAT
(http://remoat.sysbiol.cam.ac.uk), 25,349 and 1,156 probes were
unambiguously assigned to the autosomes and the X chromosome,
respectively.
Statistical Analysis
Analyses were performed at the probe level unlike other
specified. To select the transcripts that were detected in $95% of
individuals, we used the detection P-values provided by the Illumina
software and considered that a transcript was detected in a sample
when the detection P-value for that sample was ,0.05. Proportion
of detected genes between the X chromosome and autosomes were
compared using a Chi
2 test with 1df. Median expression levels
were compared between the X chromosome and autosomes using
a Mann-Whitney U test. The X:AA ratio was the ratio between
median expression levels of X-linked genes to median expression
levels of autosomal genes. The 95% bootstrap confidence interval
was estimated by resampling 1000 times the datasets of X-linked
and autosomal transcripts.
We estimated the X:AA ratio using either a common filtering
proportion of genes irrespective of the chromosomal location, or a
proportion specific of the X/autosomal location. In the former
case, we excluded the k% lowest transcripts among all transcripts,
whereas in the latter case, we excluded the k% lowest X-linked
transcripts and the k% lowest autosomal transcripts (k varying from
0% to 80%). For the comparison of the X chromosome to
individual autosome, the same proportion of genes was excluded
on each autosome and on the X.
Simulations
We simulated expression levels in 25,349 autosomal transcripts
and 1,156 X-linked transcripts under different hypotheses. For
each transcript, expression level was simulated using the model
proposed by Lin et al. [16]:
^;m~Bzmeg
where ^;m is the observed transcript level, m is the noise-free
expression level, B is the background error following a Gaussian
distribution (mB, sB) and g the multiplicative error following a
Gaussian distribution (0, sg). We simulated two different
situations in terms of proportion p of expressed genes: a first one
with equal proportions (p=80%) on the X chromosome and on
autosomes, and a second one with a lower proportion on the X
than on autosomes (p=60% vs 70%). To mimic real expression
data, m was sampled with probability p from the p% highest values
of the empirical distribution of untransformed, background-
corrected, expression levels of autosomal genes observed in GHS
data, and was set to 0 with probability 1-p. Under the hypothesis
of complete lack of dosage compensation, the value of m for X-
linked transcripts was multiplied by 0.5 to mimic the inactivation
of one X copy (X:AA=0.5). We also simulated data under a
model of partial compensation (X:AA=0.75) and full compensa-
tion (X:AA=1). Values for mB and sB were taken from the
empirical distribution of the negative controls provided by Illumina
while sg was estimated from the relation between the bead
average expression and the bead standard error as in Lin et al.
[16]. Simulated data were then transformed using the VST
transformation and the X:AA ratio was computed after filtering
out either the lowest 50% of genes irrespective of the chromosome
Dosage Compensation of the X Chromosome
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separately. The simulation was repeated 10,000 times to generate
confidence intervals.
All analyses were performed in R v. 2.10.1.
Supporting Information
Figure S1 Comparison of expression levels between the
X chromosome and autosomes in human monocytes
when selecting the most variable probe per gene (top, A:
males, B: females) or the average of probe levels by gene
(bottom, C: males, D: females). The graph plots the X:AA
ratio of median expression of X-linked genes to autosomal genes
according to the proportion of transcripts filtered out prior to
analysis, using either a uniform threshold (red triangles) or
individual thresholds on the X and on autosomes (green circles).
Error bars show the 95% bootstrap confidence intervals. The
horizontal dashed lines show the ratios expected if there was no
dosage compensation (X:AA=0.5) or full compensation
(X:AA=1).
(TIFF)
Figure S2 Comparison of expression levels between the
X chromosome and autosomes in mouse heart tissue. (A)
The graph plots the X:AA ratio of median expression of X-linked
genes to autosomal genes according to the proportion of
transcripts filtered out prior to analysis, using either a uniform
threshold (red triangles) or individual thresholds on the X and on
autosomes (green circles). Error bars show the 95% bootstrap
confidence intervals. The horizontal dashed lines show the ratios
expected if there was no dosage compensation (X:AA=0.5) or full
compensation (X:AA=1). (B) X:AA ratios when the X is
compared to individual autosomes and the same proportion of
transcripts (50%) is filtered out on the X and on each autosome.
(TIFF)
Table S1 List of the probes corresponding to imprinted
genes in the GHS dataset.
(XLS)
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